Browsing by Author "Suryadevara, Vidyani"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Lipid Mediators Regulate Pulmonary Fibrosis: Potential Mechanisms and Signaling Pathways
    (MDPI, 2020-06-15) Suryadevara, Vidyani; Ramchandran, Ramaswamy; Kamp, David W.; Natarajan, Viswanathan; Pathology and Laboratory Medicine, School of Medicine
    Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease of unknown etiology characterized by distorted distal lung architecture, inflammation, and fibrosis. The molecular mechanisms involved in the pathophysiology of IPF are incompletely defined. Several lung cell types including alveolar epithelial cells, fibroblasts, monocyte-derived macrophages, and endothelial cells have been implicated in the development and progression of fibrosis. Regardless of the cell types involved, changes in gene expression, disrupted glycolysis, and mitochondrial oxidation, dysregulated protein folding, and altered phospholipid and sphingolipid metabolism result in activation of myofibroblast, deposition of extracellular matrix proteins, remodeling of lung architecture and fibrosis. Lipid mediators derived from phospholipids, sphingolipids, and polyunsaturated fatty acids play an important role in the pathogenesis of pulmonary fibrosis and have been described to exhibit pro- and anti-fibrotic effects in IPF and in preclinical animal models of lung fibrosis. This review describes the current understanding of the role and signaling pathways of prostanoids, lysophospholipids, and sphingolipids and their metabolizing enzymes in the development of lung fibrosis. Further, several of the lipid mediators and enzymes involved in their metabolism are therapeutic targets for drug development to treat IPF.
  • Thumbnail Image
    Item
    Walk the Line: The Role of Ubiquitin in Regulating Transcription in Myocytes
    (APS, 2019-09) Suryadevara, Vidyani; Willis, Monte S.; Pathology and Laboratory Medicine, School of Medicine
    The ubiquitin-proteasome offers novel targets for potential therapies with their specific activities and tissue localization. Recently, the expansion of our understanding of how ubiquitin ligases (E3s) specifically regulate transcription has demonstrated their roles in skeletal muscle, complementing their roles in protein quality control and protein degradation. This review focuses on skeletal muscle E3s that regulate transcription factors critical to myogenesis and the maintenance of skeletal muscle wasting diseases.